Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Williamson

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid TumorsTimothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
Scientific Reports|July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
Scientific Reports|August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Nature|April 24, 2024
Phylogenomics and the rise of the angiospermsAlexandre R Zuntini, Tom Carruthers, Olivier Maurin, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid TumorsTimothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
Scientific Reports|July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
Scientific Reports|August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.
Nature|April 24, 2024
Phylogenomics and the rise of the angiospermsAlexandre R Zuntini, Tom Carruthers, Olivier Maurin, et al.
Pageof 19